SEMICONDUCTOR DEVICE
    61.
    发明申请
    SEMICONDUCTOR DEVICE 有权
    半导体器件

    公开(公告)号:US20100080058A1

    公开(公告)日:2010-04-01

    申请号:US12630295

    申请日:2009-12-03

    IPC分类号: G11C16/26 G11C16/04

    摘要: The semiconductor device includes a nonvolatile memory, having a memory array containing 1-bit twin cells, each composed of electrically rewritable first and second storage devices, the first and second storage devices holding binary data according to difference of their threshold voltages, and having different retention characteristics depending on difference of the binary data thereof; a read circuit for differentially amplifying complementary data output from the first and second storage devices of the twin cell selected for read, and judging information stored in the twin cell; and a control circuit. Two memory cells constituting a twin cell are arranged to hold different data. Therefore, even when the retention performance of one memory cell deteriorates, the difference between data held by the two memory cells can be maintained. Hence, differential amplification of such difference enables acquisition of proper stored information. Thus, retention performance of an electrically rewritable nonvolatile memory cell is improved.

    摘要翻译: 半导体器件包括非易失性存储器,具有包含1比特双胞胞的存储器阵列,每个存储器阵列由电可重写的第一和第二存储器件组成,第一和第二存储器件根据其阈值电压的差异保持二进制数据,并具有不同的 保留特性取决于其二进制数据的差异; 用于差分放大从被选择读取的双胞胎的第一和第二存储装置输出的互补数据的读取电路,以及判断存储在双胞胎中的信息; 和控制电路。 布置构成双胞胎的两个存储单元以保存不同的数据。 因此,即使一个存储单元的保持性能劣化,也能够维持由两个存储单元保持的数据之间的差异。 因此,这种差异的差分放大使得能够获得正确的存储信息。 因此,提高了电可重写非易失性存储单元的保持性能。

    Driving system and optical-element driving system
    62.
    发明授权
    Driving system and optical-element driving system 有权
    驱动系统和光学元件驱动系统

    公开(公告)号:US07684136B2

    公开(公告)日:2010-03-23

    申请号:US12208443

    申请日:2008-09-11

    IPC分类号: G02B7/02

    CPC分类号: G03F7/70825

    摘要: A driving system for driving an optical element in a first direction includes a linear actuator for producing a displacement in a second direction perpendicular to the first direction, a displacement picking unit being extendable in a third direction, perpendicular to both of the first and second directions, for picking out a displacement of the linear actuator, and a direction converting unit disposed at the third-direction side of the linear actuator, for converting a direction of the displacement picked out by the displacement picking unit.

    摘要翻译: 用于在第一方向上驱动光学元件的驱动系统包括用于在与第一方向垂直的第二方向上产生位移的线性致动器,位移拾取单元可沿第三方向延伸,垂直于第一和第二方向 ,用于拾取线性致动器的位移,以及设置在线性致动器的第三方侧的方向转换单元,用于转换由位移拾取单元拾取的位移方向。

    DRIVING MECHANISM AND OPTICAL ELEMENT DRIVING APPARATUS
    64.
    发明申请
    DRIVING MECHANISM AND OPTICAL ELEMENT DRIVING APPARATUS 有权
    驱动机构和光学元件驱动装置

    公开(公告)号:US20080204905A1

    公开(公告)日:2008-08-28

    申请号:US12029539

    申请日:2008-02-12

    IPC分类号: G02B7/04

    摘要: An optical-element driving mechanism is configured to drive an optical element, and includes a uniaxial driving mechanism that includes a linear actuator that drives in a first direction, and a link mechanism that converts a displacement in a direction orthogonal to the first direction. The linear actuator is level with the link mechanism in an optical-axis direction. The uniaxial driving mechanism is arranged in order of the link mechanism and the linear actuator in a radial direction when viewed form an optical axis of the optical element.

    摘要翻译: 光学元件驱动机构被配置为驱动光学元件,并且包括单轴驱动机构,该单轴驱动机构包括沿第一方向驱动的线性致动器和连接机构,该连杆机构转换与第一方向正交的方向的位移。 线性致动器与链接机构在光轴方向上平齐。 当从光学元件的光轴观察时,单轴驱动机构按照连杆机构和线性致动器的径向方向排列。

    Methods for prevention and treatment of arteriosclerosis and restenosis
    65.
    发明申请
    Methods for prevention and treatment of arteriosclerosis and restenosis 审中-公开
    预防和治疗动脉硬化和再狭窄的方法

    公开(公告)号:US20080176910A1

    公开(公告)日:2008-07-24

    申请号:US12074779

    申请日:2008-03-06

    IPC分类号: A61K31/455 A61P9/10 A61K31/41

    摘要: Methods for the prevention and/or treatment of arteriosclerosis and restenosis following percutaneous coronary intervention or sudden death and for the inhibition of vascular smooth muscle cells, neointima formulation of blood vessels or vascular remodeling comprising administering to a mammal, such as a human, in need thereof pharmaceutically effective amounts of an angiotensin II receptor antagonist which is (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate and a calcium channel blocker which is amlodipine or amlodipine besylate.

    摘要翻译: 用于预防和/或治疗经皮冠状动脉介入或猝死以及抑制血管平滑肌细胞,血管新生内膜制剂或血管重塑后的动脉硬化和再狭窄的方法,其包括向有需要的哺乳动物(例如人)施用 其为药学上有效量的血管紧张素II受体拮抗剂,其为4-(1-羟基-1-甲基乙基)-2-丙基-1-(5-甲基-2-氧代-1,3-二氧杂环戊烯-4-基) [[2' - (1H-四唑-5-基)联苯-4-基]甲基]咪唑-5-羧酸酯和钙通道阻断剂,其是氨氯地平或苯磺酸氨氯地平。

    SEMICONDUCTOR DEVICE
    67.
    发明申请
    SEMICONDUCTOR DEVICE 有权
    半导体器件

    公开(公告)号:US20080089146A1

    公开(公告)日:2008-04-17

    申请号:US11869144

    申请日:2007-10-09

    IPC分类号: G11C7/00

    摘要: The semiconductor device includes a nonvolatile memory, having a memory array containing 1-bit twin cells, each composed of electrically rewritable first and second storage devices, the first and second storage devices holding binary data according to difference of their threshold voltages, and having different retention characteristics depending on difference of the binary data thereof; a read circuit for differentially amplifying complementary data output from the first and second storage devices of the twin cell selected for read, and judging information stored in the twin cell; and a control circuit. Two memory cells constituting a twin cell are arranged to hold different data. Therefore, even when the retention performance of one memory cell deteriorates, the difference between data held by the two memory cells can be maintained. Hence, differential amplification of such difference enables acquisition of proper stored information. Thus, retention performance of an electrically rewritable nonvolatile memory cell is improved.

    摘要翻译: 半导体器件包括非易失性存储器,具有包含1比特双胞格的存储器阵列,每个存储器阵列由电可重写的第一和第二存储器件组成,第一和第二存储器件根据其阈值电压的差异保持二进制数据,并且具有不同的 保留特性取决于其二进制数据的差异; 用于差分放大从被选择读取的双胞胎的第一和第二存储装置输出的互补数据的读取电路,以及判断存储在双胞胎中的信息; 和控制电路。 布置构成双胞胎的两个存储单元以保存不同的数据。 因此,即使一个存储单元的保持性能劣化,也能够维持由两个存储单元保持的数据之间的差异。 因此,这种差异的差分放大使得能够获得正确的存储信息。 因此,提高了电可重写非易失性存储单元的保持性能。

    ANTI-VIBRATION APPARATUS, EXPOSURE APPARATUS, AND DEVICE MANUFACTURING METHOD
    68.
    发明申请
    ANTI-VIBRATION APPARATUS, EXPOSURE APPARATUS, AND DEVICE MANUFACTURING METHOD 审中-公开
    防振装置,曝光装置和装置制造方法

    公开(公告)号:US20080068603A1

    公开(公告)日:2008-03-20

    申请号:US11846904

    申请日:2007-08-29

    IPC分类号: G01N21/01 G03B27/62 H01S4/00

    摘要: An anti-vibration apparatus includes a target object, a reference object, a measuring device which measures the position of the target object relative to the reference object, a driving mechanism to drive the target object based on the measurement result obtained by the measuring device, a Lorentz's force actuator which supports the reference object, and a power supply device which supplies a constant current to the Lorentz's force actuator. The actuator which supports the reference object uses a Lorentz's force actuator or an actuator which supports the reference object by the pressure of a gas.

    摘要翻译: 防振装置包括目标物体,参考物体,测量目标物体相对于基准物体的位置的测量装置,基于由测量装置获得的测量结果来驱动目标物体的驱动机构, 支撑参考对象的洛伦兹力致动器,以及向洛伦兹力致动器提供恒定电流的电源装置。 支撑参考对象的致动器使用洛仑兹力致动器或通过气体压力支撑参考对象的致动器。

    Medicine for prevention of and treatment for arteriosclerosis and hypertension
    70.
    发明申请
    Medicine for prevention of and treatment for arteriosclerosis and hypertension 审中-公开
    用于预防和治疗动脉硬化和高血压的药物

    公开(公告)号:US20060252805A1

    公开(公告)日:2006-11-09

    申请号:US11484132

    申请日:2006-07-11

    IPC分类号: A61K31/455 A61K31/4184

    摘要: A pharmaceutical composition comprising the following active ingredients: (A) an angiotensin II receptor antagonist which is (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1 [[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate and (B) a calcium channel blocker which is amlodipine. The composition is useful for the prophylaxis and/or treatment of arteriosclerosis, hypertension, heart diseases, renal diseases or cerebrovascular diseases.

    摘要翻译: 一种药物组合物,其包含以下活性成分:(A)血管紧张素II受体拮抗剂,其为4-(1-羟基-1-甲基乙基)(5-甲基-2-氧代-1,3-二氧杂环戊烯-4-基) -2-丙基-1 [[2' - (1H-四唑-5-基)联苯-4-基]甲基]咪唑-5-羧酸甲酯和(B)钙通道阻断剂,其为氨氯地平。 该组合物可用于预防和/或治疗动脉硬化,高血压,心脏病,肾脏疾病或脑血管疾病。